PuriCore, the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, announces that its Sterilox Solution has been proven highly effective against pandemic H5N1 avian influenza, a highly contagious and lethal outbreak pathogen. The research showed that Sterilox Solution completely inactivated the H5N1 test strain and passed the US Environmental Protection Agencyʼs recommended hard-surface disinfection test, which requires two-minutes contact time.
The study conducted by ATS Labs, an independent certified laboratory, tested the virucidal activity of the
Sterilox Solution in decontaminating H5N1 avian influenza on hard surfaces. Previous PuriCore studies
proved the effectiveness of Sterilox Solution against a common surrogate for the pandemic H5N1 avian
influenza strain, the human influenza virus, A/Hong Kong 68 Strain. This new H5N1 research builds upon
PuriCore´s earlier microbiological research, including published studies last year showing the effectiveness
of the Sterilox Solution against major outbreak pathogens such as norovirus, MRSA, and acinetobacter.
